4th Quarter - Report

THE MCMANUS GROUP for ALLERGAN INC

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

FDA approval and enforcement issues. Cosmetics products in 340B.

Foreign entity interest: 100% ownership by Allergan plc, Clonshaugh Business and Technology Park, Coolock, Dublin, D17 E400, Ireland.

LobbyistCovered position, as disclosed
JOHN MCMANUS —
BARRETT THORNHILL —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

Opposition to proposed Part B demo (81 FR 13229). Education regarding CMMI. Support for H.R.5122 - To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models.

Foreign entity interest: 100% ownership by Allergan plc, Clonshaugh Business and Technology Park, Coolock, Dublin, D17 E400, Ireland.

LobbyistCovered position, as disclosed
JOHN MCMANUS —
BARRETT THORNHILL —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 5122 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.